In 2004, a team of Dana-Farber doctors discovered a gene mutation that could treated by a drug on the market for something else. This discovery transformed the way lung cancer is treated and began an era of precision medicine for lung cancer.
4/23/2014 12:40 PM EDT
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved the first targeted drug as treatment for advanced stomach cancer.
4/21/2014 5:00 PM EDT
A new study by researchers at Dana-Farber Cancer Institute suggests that not all doctors are ready to embrace tests that look for hundreds of DNA changes in patients’ tumor samples, while others plan to offer this type of cancer gene testing to...
3/21/2014 4:00 PM EDT
A patient with advanced bladder cancer in a phase I trial had a complete response for 14 months to a combination of the targeted drugs everolimus and pazopanib, and genomic profiling of his tumor revealed two alterations that may have led to this...
3/12/2014 12:30 PM EDT
Study Shows More Hospital Deaths and Invasive Care for Dying Cancer Patients Who Receive Chemotherapy
A study by researchers at Dana-Farber Cancer Institute and Weill Cornell Medical College shows terminal cancer patients who receive chemotherapy in the last months of their lives are less likely to die where they want and are more likely to undergo...
2/28/2014 11:00 AM EST
Nivolumab, a drug that unleashes the immune system to attack cancer, has shown to produce lasting remissions and hold the disease in check – for more than two years, in some cases – in many patients with advanced melanoma, according to a new...
3/3/2014 2:45 PM EST
A normal enzyme called SYK pairs with FLT3, the most commonly mutated enzyme in acute myelogenous leukemia, to promote cancer growth & resistance to treatment with FLT3-blocking drugs. In mouse model, treatment with a drug combination to inhibit...
2/10/2014 2:00 PM EST
Long-Term Survival Among Patients with Most Common Childhood Brain Tumor Is High; Lower if Treatment Included Radiation
Study of long-term survival of children with most common pediatric brain tumor finds almost 90 percent are alive 20 years later and few died from the tumor as adults. However, children treated with radiation had significantly lower long-term...
2/3/2014 3:40 PM EST
With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
3/5/2014 5:00 PM EST
11/11/2013 5:00 PM EST
National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support
9/17/2013 3:00 PM EDT
The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
6/7/2013 12:00 PM EDT
5/24/2013 3:00 PM EDT
Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
5/17/2013 8:00 AM EDT
The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
10/23/2009 1:00 PM EDT